Vineet Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹50
- Today's High:
- ₹53.6
- Open Price:
- ₹53.6
- 52W Low:
- ₹38.2
- 52W High:
- ₹74.6
- Prev. Close:
- ₹53.73
- Volume:
- 8251
Company Statistics
- Market Cap.:
- ₹478.56 million
- Book Value:
- 35.288
- Revenue TTM:
- ₹2.01 billion
- Operating Margin TTM:
- 0.78%
- Gross Profit TTM:
- ₹400.88 million
- Profit Margin:
- -0.5%
- Return on Assets TTM:
- 0.87%
- Return on Equity TTM:
- -3.02%
Company Profile
Vineet Laboratories Limited had its IPO on under the ticker symbol VINEETLAB.
The company operates in the Basic Materials sector and Chemicals industry. Vineet Laboratories Limited has a staff strength of 0 employees.
Stock update
Shares of Vineet Laboratories Limited opened at ₹53.6 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹50 - ₹53.6, and closed at ₹50.6.
This is a -5.83% slip from the previous day's closing price.
A total volume of 8,251 shares were traded at the close of the day’s session.
In the last one week, shares of Vineet Laboratories Limited have slipped by -2.97%.
Vineet Laboratories Limited's Key Ratios
Vineet Laboratories Limited has a market cap of ₹478.56 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Vineet Laboratories Limited’s revenue was ₹2.01 billion with a gross profit of ₹400.88 million and an EBITDA of ₹39.92 million. The EBITDA ratio measures Vineet Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Vineet Laboratories Limited’s operating margin was 0.78% while its return on assets stood at 0.87% with a return of equity of -3.02%.
In Q2, Vineet Laboratories Limited’s quarterly earnings growth was a positive 9.4% while revenue growth was a negative 23.1%.
Vineet Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹-1.1 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vineet Laboratories Limited’s profitability.
Vineet Laboratories Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Vineet Laboratories Limited stock pays annual dividends of ₹0 per share, indicating a yield of 1.96% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.08 billion
- Total Liabilities
- ₹673.68 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Vineet Laboratories Limited ended 2024 with ₹1.08 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.08 billion while shareholder equity stood at ₹324.33 million.
Vineet Laboratories Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹673.68 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0.00 in goodwill. Its cash balance stood at ₹6.81 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹57.27 million.
Vineet Laboratories Limited’s total current assets stands at ₹803.56 million while long-term investments were ₹0 and short-term investments were ₹2.97 million. Its net receivables were ₹352.76 million compared to accounts payable of ₹397.99 million and inventory worth ₹406.92 million.
In 2024, Vineet Laboratories Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Vineet Laboratories Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹50.6
- 52-Week High
- ₹74.6
- 52-Week Low
- ₹38.2
- Analyst Target Price
- ₹
Vineet Laboratories Limited stock is currently trading at ₹50.6 per share. It touched a 52-week high of ₹74.6 and a 52-week low of ₹74.6. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹52.73 and 200-day moving average was ₹51.85 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4873.5% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Vineet Laboratories Limited
Similar Industry Stocks (Chemicals)
Most Active
Top Gainers
Top Losers
About
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients and fine chemicals in India. It offers intermediates of lopinavir, ritonavir, efavirenz, nadolol, glimepiride, celecoxib, olanine, and other API intermediates; and fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.